Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis
- PMID: 19204111
- PMCID: PMC2646568
- DOI: 10.1084/jem.20081463
Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis
Abstract
The commensal fungus Candida albicans causes oropharyngeal candidiasis (OPC; thrush) in settings of immunodeficiency. Although disseminated, vaginal, and oral candidiasis are all caused by C. albicans species, host defense against C. albicans varies by anatomical location. T helper 1 (Th1) cells have long been implicated in defense against candidiasis, whereas the role of Th17 cells remains controversial. IL-17 mediates inflammatory pathology in a gastric model of mucosal candidiasis, but is host protective in disseminated disease. Here, we directly compared Th1 and Th17 function in a model of OPC. Th17-deficient (IL-23p19(-/-)) and IL-17R-deficient (IL-17RA(-/-)) mice experienced severe OPC, whereas Th1-deficient (IL-12p35(-/-)) mice showed low fungal burdens and no overt disease. Neutrophil recruitment was impaired in IL-23p19(-/-) and IL-17RA(-/-), but not IL-12(-/-), mice, and TCR-alphabeta cells were more important than TCR-gammadelta cells. Surprisingly, mice deficient in the Th17 cytokine IL-22 were only mildly susceptible to OPC, indicating that IL-17 rather than IL-22 is vital in defense against oral candidiasis. Gene profiling of oral mucosal tissue showed strong induction of Th17 signature genes, including CXC chemokines and beta defensin-3. Saliva from Th17-deficient, but not Th1-deficient, mice exhibited reduced candidacidal activity. Thus, the Th17 lineage, acting largely through IL-17, confers the dominant response to oral candidiasis through neutrophils and antimicrobial factors.
Figures
Comment in
-
Rethinking T cell immunity in oropharyngeal candidiasis.J Exp Med. 2009 Feb 16;206(2):269-73. doi: 10.1084/jem.20090093. Epub 2009 Feb 9. J Exp Med. 2009. PMID: 19204107 Free PMC article.
References
-
- Klein R.S., Harris C.A., Small C.B., Moll B., Lesser M., Friedland G.H. 1984. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome.N. Engl. J. Med. 311:354–358 - PubMed
-
- Dongari-Bagtzoglou A., Fidel P. 2005. The host cytokine responses and protective immunity in oropharyngeal candidiasis.J. Dent. Res. 84:966–977 - PubMed
-
- Scully C., el-Kabir M., Samaranayake L.P. 1994. Candida and oral candidosis: a review.Crit. Rev. Oral Biol. Med. 5:125–157 - PubMed
-
- Fidel P.L., Sobel J.D. 1998. Protective immunity in experimental Candida vaginitis.Res. Immunol. 149:361–373 - PubMed
-
- Ghilardi N., Ouyang W. 2007. Targeting the development and effector functions of Th17 cells.Semin. Immunol. 19:383–393 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
